当前位置:首页 - 行情中心 - 健帆生物(300529) - 财务分析 - 现金流量表

健帆生物

(300529)

  

流通市值:99.50亿  总市值:155.33亿
流通股本:5.12亿   总股本:7.99亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,768,386,740.741,299,776,192.19605,506,283.552,968,564,959.49
  收到的税费返还946,942.18797,579.13427,508.821,412,149.21
  收到其他与经营活动有关的现金96,557,078.25102,177,855.852,637,880.561,223,715.07
  经营活动现金流入小计1,865,890,761.171,402,751,627.12658,571,672.873,031,200,823.77
  购买商品、接受劳务支付的现金305,564,662.82188,856,764.35108,555,827.23337,539,883.33
  支付给职工以及为职工支付的现金407,206,778.95290,208,099.41133,698,395.11619,071,241.96
  支付的各项税费314,020,246.06214,627,171.3669,901,768.04469,527,502.11
  支付其他与经营活动有关的现金265,858,918.17170,778,156.6177,361,893.68554,073,774.97
  经营活动现金流出小计1,292,650,606864,470,191.73389,517,884.061,980,212,402.37
  经营活动产生的现金流量净额573,240,155.17538,281,435.39269,053,788.811,050,988,421.4
二、投资活动产生的现金流量:
  收回投资收到的现金1,919,605,241.541,778,730,364.61649,212,907.893,732,950,000
  取得投资收益收到的现金8,757,199.68,378,243.26619,349.8942,089,876.63
  处置固定资产、无形资产和其他长期资产收回的现金净额2,440,528.291,665,940.291,454,9505,340,781.35
  投资活动现金流入小计1,930,802,969.431,788,774,548.16651,287,207.783,780,380,657.98
  购建固定资产、无形资产和其他长期资产支付的现金118,273,187.5988,819,929.4152,431,942.8235,140,028.4
  投资支付的现金3,054,950,0002,589,950,0002,129,950,0004,672,712,907.89
  投资活动现金流出小计3,173,223,187.592,678,769,929.412,182,381,942.84,907,852,936.29
  投资活动产生的现金流量净额-1,242,420,218.16-889,995,381.25-1,531,094,735.02-1,127,472,278.31
三、筹资活动产生的现金流量:
  取得借款收到的现金78,265,413.3145,151,704.6634,691,084.41325,075,677.25
  收到其他与筹资活动有关的现金449,965,192.8928,796,931.828,380,023.6694,342,749.36
  筹资活动现金流入小计528,230,606.273,948,636.4843,071,108.07419,418,426.61
  偿还债务支付的现金32,120,327.4432,110,857.4416,530,548.64651,161,297.67
  分配股利、利润或偿付利息支付的现金640,672,599.99639,269,472.461,373,115.22340,117,509.67
  支付其他与筹资活动有关的现金451,907,353.5130,041,154.449,224,864.26417,960,680.74
  筹资活动现金流出小计1,124,700,280.94701,421,484.3427,128,528.121,409,239,488.08
  筹资活动产生的现金流量净额-596,469,674.74-627,472,847.8615,942,579.95-989,821,061.47
四、汇率变动对现金及现金等价物的影响-525,067.8593,947.11145,379.17427,871.75
五、现金及现金等价物净增加额-1,266,174,805.58-979,092,846.61-1,245,952,987.09-1,065,877,046.63
  加:期初现金及现金等价物余额1,675,666,241.251,675,666,241.251,675,666,241.252,741,543,287.88
  期末现金及现金等价物余额409,491,435.67696,573,394.64429,713,254.161,675,666,241.25
补充资料:
  净利润-388,668,556.92-814,186,376.79
  资产减值准备-3,760,902.26-10,843,712.79
  固定资产和投资性房地产折旧-58,730,030.61-119,604,861.51
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-58,730,030.61-119,604,861.51
  无形资产摊销-2,156,071.63-4,311,430.23
  长期待摊费用摊销-8,569,780.78-16,954,528.37
  处置固定资产、无形资产和其他长期资产的损失-1,413,498.67--3,639,820.27
  固定资产报废损失-682,958.8-1,041,823.84
  公允价值变动损失--21,552,025.71--1,023,228.9
  财务费用-26,807,559.18-63,713,298.39
  投资损失--8,330,958.77--42,089,876.63
  递延所得税--16,190,686.97--5,476,591.81
  其中:递延所得税资产减少--19,190,904.39--4,233,114.23
    递延所得税负债增加-3,000,217.42--1,243,477.58
  存货的减少-3,277,523.29-41,562,239.31
  经营性应收项目的减少-5,518,555.37--8,217,395.2
  经营性应付项目的增加-65,044,209.58-451,180.84
  其他-18,574,999.98-35,486,882.63
  现金的期末余额-696,573,394.64-1,675,666,241.25
  减:现金的期初余额-1,675,666,241.25-2,741,543,287.88
  现金及现金等价物的净增加额--979,092,846.61--1,065,877,046.63
公告日期2025-10-302025-08-222025-04-162025-04-16
审计意见(境内)标准无保留意见
TOP↑